KEY FINDINGS The global market of metagenomics is forecasted to grow at a CAGR of 15.21% between the years 2019-2027. Along with the study of the interaction of microbes, metagenomics also consists the analysis of the collective genomes.
MARKET INSIGHTS The factors responsible for the growth of metagenomics market is the increase in metagenomics experiments collaboration, adoption of metagenomics application and growing advanced sequencing platforms.A collaboration between the scientific experiments and computing technologies is driving the metagenomics market through the experiments collaboration.
The consumables product segment generated the highest revenue in 2018 and is expected to stay dominant throughout the forecast period. Based on application, the infectious disease diagnosis segment has registered the fastest growth rate throughout the forecast period.Two commonly used metagenomics methods in the pathogen identification of infectious disease diagnosis include deep amplicon sequencing and whole-genome shotgun metagenomics.
However, the metagenomics market faces some troubles when it comes to the availability of skilled personnel and regulations.
REGIONAL INSIGHTS Based on geography, the global metagenomics market has been segmented into geographical regions, which include North America, Europe, Asia-Pacific, and Rest of the World.The major countries considered in every region are, North America (the United States, and Canada), Europe (United Kingdom, France, Germany, Italy, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of Asia Pacific).
Rest of World segment includes key regions such as Latin America & Middle East and Africa. In 2018, the majority of market share was captured by North America in the Global metagenomics market by region. North America contributed approx. xx% of market share in 2018 & is estimated to contribute the majority of share to remain at approx. xx% by 2027 as compared to 2018. On the other hand, Asia-Pacific is anticipated to be the fastest growing region in the market with a CAGR of xx% during the forecast period 2019-2027.
COMPETITIVE INSIGHTS Some of the leading players in the market are Agilent Technologies Inc., Interagen SA, Oxford nanopore technology, Perkin Elmer Inc., Bio-Rad Laboratories Inc., Enterome SA, F Hoffman La-Roche Ltd, Qiagen NV, Swift Biosciences Inc., Pacific Biosciences of California, Illumina Inc., Takara Bio Inc. and Thermo Fisher Scientific Inc.
Companies mentioned 1. AGILENT TECHNOLOGIES, INC. 2. BIO-RAD LABORATORIES, INC. 3. ENTEROME SA 4. F. HOFFMANN-LA ROCHE LTD 5. ILLUMINA, INC. 6. INTEGRAGEN S.A 7. OXFORD NANOPORE TECHNOLOGIES LTD. 8. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 9. PERKINELMER, INC. 10. QIAGEN N.V. 11. SWIFT BIOSCIENCES INC. 12. TAKARA BIO, INC. 13. THERMO FISHER SCIENTIFIC INC.
Our reports have been used by over 10K customers, including:
168 pages •
By Global Industry Analysts
• Apr 2021
- Global Spatial Genomics and Transcriptomics Market to Reach $275.8 Million by 2027
- Amid the COVID-19 crisis, the global market for Spatial Genomics and Transcriptomics estimated at US$170.7 Million in the year 2020, is projected to reach a revised size of US$275.8 Million by 2027, growing at a CAGR of...
Global Single-Cell Multi-Omics Market to Reach $3,188.9 Million by 2025 Market Report Coverage - Single-Cell Multi-Omics Market Segmentation • Product Type – Consumables, Instruments, and Software • Sample Type – Human Samples, Animal Samples, and Microbial Samples • Omics Type –...
Spatial Genomics & Transcriptomics Market Report Overview Spatial Genomics & Transcriptomics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Spatial Genomics & Transcriptomics market types and applications. It is a focused study on...
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries....
178 pages •
By Global Industry Analysts
• Apr 2021
- Global RNA Analysis/Transcriptomics Market to Reach $8.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for RNA Analysis/Transcriptomics estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$8.7 Billion by 2027, growing at a CAGR of 13.1% over the analysis...
Transcriptomics Market Report Overview Transcriptomics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Transcriptomics market types and applications. It is a focused study on Transcriptomics market space including global and regional...
The global spatial genomics and transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications...
Global Spatial Genomics and Transcriptomics Market to Reach $2,173.0 Million by 2030 Market Report Coverage - Spatial Genomics and Transcriptomics Market Segmentation • Product Type – Kits and Assays, Instruments, Software, and Services • Sample Type – Fresh Frozen Tissues, Fixed Frozen...
Transcriptomics Technologies Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Transcriptomics Technologies market including the COVID-19 pandemic...
23andMe, Inc - Tech Innovator Profile
23andMe, Inc. (23andMe) is a personal genomics and biotechnology company that leverages machine learning (ML) technology to provide DNA analysis services.
The report provides information and insights into 23andMe, Inc.’s, including...
Genomics Proteomics And Enabling Technology
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.